The clinical characteristics and outcomes of patients with human granulocytic anaplasmosis in China

International Journal of Infectious Diseases

Volumn 15, Issue 12, 2011, Pages

  Li, Huiyu ^a   Zhou, Yan ^a   Wang, Wenjie ^a   Guo, Dongmei ^a   Huang, Shiang ^a   Jie, Shenghua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Clinical characteristics; Human granulocytic anaplasmosis; Multiple organ dysfunction syndrome; Outcomes; Systemic inflammatory response syndrome

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; DOXYCYCLINE; LACTATE DEHYDROGENASE; RIFAMPICIN;

ADULT; AGED; ARTICLE; CHINA; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; EPIDEMIC; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; ANTIBODIES, BACTERIAL; ARACHNID VECTORS; CHINA; COHORT STUDIES; DISEASE OUTBREAKS; EHRLICHIOSIS; FEMALE; GRANULOCYTES; HUMANS; INCIDENCE; IXODES; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 82455216822     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.09.008     Document Type: Article

References (28)

1. Dumler J.S., Choi K.S., Garcia-Garcia J.C., Barat N.S., Scorpio D.G., Garyu J.W., et al. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis 2005, 11:1828-1834.
2. Demma L.J., Holman R.C., McQuiston J.H., Krebs J.W., Swerdlow D.L. Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am J Trop Med Hyg 2005, 73:400-409.
3. Chen S.M., Dumler J.S., Bakken J.S., Walker D.H. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994, 32:589-595.
4. Dhand A., Nadelman R.B., Aguero-Rosenfeld M., Haddad F.A., Stokes D.P., Horowitz H.W. Human granulocytic anaplasmosis during pregnancy: case series and literature review. Clin J Infect Dis 2007, 45:589-593.
5. Zhang S., Hai R., Li W., Li G., Lin G., He J., et al. Seroprevalence of human granulocytotropic anaplasmosis in central and southeastern China. Am J Trop Med Hyg 2009, 81:293-295.
6. Zhang L., Liu Y., Ni D., Li Q., Yu Y., Yu X.J., et al. Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA 2008, 300:2263-2270.
7. Keysary A., Massung R.F., Inbar M., Wallach A.D., Shanas U., Mumcuoglu K.Y., et al. Molecular evidence for Anaplasma phagocytophilum in Israel. Emerg Infect Dis 2007, 13:1411-1412.
8. Ohashi N., Inayoshi M., Kitamura K., Kawamori F., Kawaguchi D., Nishimura Y., et al. Anaplasma phagocytophilum-infected ticks. Japan Emerg Infect Dis 2005, 11:1780-1783.
9. Cao W.C., Zhao Q.M., Zhang P.H., Dumler J.S., Zhang X.T., Fang L.Q., et al. Granulocytic ehrlichiae in Ixodes persulcatus ticks from an area in China where Lyme disease is endemic. J Clin Microbiol 2000, 38:4208-4210.
10. Pancholi P., Kolbert C.P., Mitchell P.D., Reed K.D., Dumler J.S., Bakken J.S., et al. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 1995, 172:1007-1012.
11. Kramer V.L., Randolph M.P., Hui L.T., Irwin W.E., Gutierrez A.G., Vugia D.J. Detection of the agents of human ehrlichioses in ixodid ticks from California. Am J Trop Med Hyg 1999, 60:62-65.
12. Pusterla N., Leutenegger C.M., Huder J.B., Weber R., Braun U., Lutz H. Evidence of the human granulocytic ehrlichiosis agent in Ixodes ricinus ticks in Switzerland. J Clin Microbiol 1999, 37:1332-1334.
13. Wen B., Cao W., Pan H. Ehrlichiae and ehrlichial diseases in China. Ann N Y Acad Sci 2003, 990:45-53.
14. Dumler J.S., Bakken J.S. Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med 1998, 49:201-213.
15. Bakken J.S., Dumler J.S. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci 2006, 1078:236-247.
16. Chapman A.S., Bakken J.S., Folk S.M., Paddock C.D., Bloch K.C., Krusell A., et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006, 55:1-27.
17. Anaplasma phagocytophilum indirect immunofluorescence antibody (IF) IgG test (Product Code IF1400G). Cypress, CA: FOCUS Diagnostics; 2004.
18. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
19. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., Sibbald W.J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652.
20. Centers for Disease Control and Prevention (CDC). Anaplasma phagocytophilum transmitted through blood transfusion-Minnesota, 2007. MMWR Morb Mortal Wkly Rep 2008;57:1145-8.
21. Bakken J.S., Krueth J., Wilson-Nordskog C., Tilden R.L., Asanovich K., Dumler J.S. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996, 275:199-205.
22. Xiong Q.M., Wang X.Q., Rikihisa Y. High-cholesterol diet facilitates Anaplasma phagocytophilum infection and up-regulates macrophage inflammatory protein-2 and CXCR2 expression in apolipoprotein E-deficient mice. J Infect Dis 2007, 195:1497-1503.
23. Bakken J.S., Krueth J.K., Lund T., Mallkovitch D., Asanovich K., Dumler J.S. Exposure to deer blood may be a cause of human granulocytic ehrlichiosis. Clin Infect Dis 1996, 23:198.
24. Dumler J.S., Madigan J.E., Pusterla N., Bakken J.S. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 2007, 45:S45-S51.
25. Wormser G.P., Dattwyler R.J., Shapiro E.D., Halperin J.J., Steere A.C., Klempner M.S., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1134.
26. Purvis J.J., Edwards M.S. Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J 2000, 19:871-874.
27. Bakken J.S., Dumler J.S. Human granulocytic anaplasmosis. Infect Dis Clin North Am 2008, 22:433-448.
28. Petrovec M., Lotric Furlan S., Zupanc T.A., Strle F., Brouqui P., Roux V., et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997, 35:1556-1559.